Lirum Therapeutics
PrivateLast Round
IPO
Mar 11, 2024
Est. Valuation
$45M
Company Overview
Lirum Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Private Placement round in February 2023.
Lirum Therapeutics is a clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development, and commercialization of novel drug candidates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lirum Therapeutics Comparables
Compare Lirum Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sling Therapeutics | 83% | |
| Astellas Pharma Inc. | 80% | |
| Acelyrin | 77% |
For institutional investors. Book with your work email.
Lirum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Mar 11, 2024 | ||||
| Private Placement | Feb 8, 2023 |
For institutional investors. Book with your work email.
Lirum Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lirum Therapeutics's valuation, stock price, and market status.
Is Lirum Therapeutics a public or private company?
Lirum Therapeutics is a private company.
What is the current stock price of Lirum Therapeutics?
Lirum Therapeutics is a private company, so its shares have no public market price. Caplight tracks Lirum Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lirum Therapeutics worth (valuation)?
Lirum Therapeutics's valuation is estimated at $45.0M based on funding round data.
Can I buy Lirum Therapeutics stock?
Lirum Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lirum Therapeutics's last funding round?
Lirum Therapeutics's most recent funding round was IPO on March 11, 2024.
Who are the main investors in Lirum Therapeutics?
Investor information for Lirum Therapeutics is not publicly disclosed.
Will Lirum Therapeutics IPO soon?
No public IPO plans have been announced for Lirum Therapeutics.
How can I track Lirum Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Lirum Therapeutics's shares on secondary markets.